top of page

Coalition for Compounding Excellence

A Fresh, Affordable Pathway to Compliance and Quality For the Compounding Pharmacy Industry

The ONLY Risk-Based Auditing and Accreditation Model in Compounding

NEW! PEPTIDE PRACTICE VERIFICATION PROGRAM

Search

US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs

May 6

0 min read

Recent Posts

The gray market just got a little less gray in Mississippi

The gray market just got a little less gray in Mississippi

FDA moves to exclude three GLP-1s from 503B compounding

Statement from the Alliance for Pharmacy Compounding on FDA Proposed Rule Regarding 503B Bulks List

Comments

bottom of page